News Archives Archives - Page 6 of 293

UNC Lineberger's Dirk Dittmer, PhD, Joel Parker, PhD, and Sara Selitsky, PhD.

UNC Lineberger’s Dirk Dittmer, PhD, Joel Parker, PhD, Sara Selitsky, PhD, and colleagues published a new study in the journal mSystems, an open access journal of the American Society for Microbiology. The study used data from The Cancer Genome Atlas project to explore whether Epstein-Barr virus is linked with additional cancer types beyond gastric cancer, nasopharyngeal carcinoma, and certain lymphomas, which have been convincingly linked to infection with the virus.

H. Shelton Earp, MD, and G. Greg Wang, PhD, have published a study that describe the role of androgen receptor variant 7 (AR-V7), an alternative form of the androgen receptor, that plays a key role in prostate cancer development.

In the journal Molecular Cell, researchers led by UNC Lineberger's G. Greg Wang, PhD, and H. Shelton Earp, MD, describe the role of a protein variant called androgen receptor variant 7 (AR-V7), which is an alternative form of the androgen receptor that plays a key role in prostate cancer development and treatment.

Stephanie Wheeler, PhD, MPH, and colleagues found that women with advanced breast cancer experience significant financial hardships associated with having the disease.

A study led by UNC Lineberger's Stephanie Wheeler, PhD, investigated the extent and severity of negative financial effects of cancer among women with breast cancer that has spread in the body. The preliminary results were presented at the American Society of Clinical Oncology’s Quality Care Symposium, held Sept. 28-29 in Phoenix.

UNC Lineberger's Paul A. Dayton, PhD, and his colleagues have been awarded a five-year, $3.2 million grant from the National Cancer Institute to investigate how to improve radiation treatment for pet dogs undergoing treatment for sarcoma.

UNC Lineberger's Lisa Carey, MD, was elected to ASCO board of directors

Included in the new investments by Susan G. Komen was $400,000 for UNC Lineberger’s Lisa Carey, MD, the physician-in-chief of the N.C. Cancer Hospital, Richardson and Marilyn Jacobs Preyer Distinguished Professor in Breast Cancer Research, chief of the UNC School of Medicine Division of Hematology/Oncology, and a member of the Komen Scientific Advisory Board, for a study of HER2-positive breast cancer.

UNC School of Medicine, UNC Medical Center, and NC TraCS Institute awarded $50,000 to two teams of researchers led by UNC Lineberger's Jill Bates, PharmD, clinical oncology precision medicine pharmacist, along with Alison Stuebe, MD, and Ana Whitney, MS, to study pharmacogenomics and social determinants of maternal health.

Category: News Archives

UNC Lineberger researchers published in mSystems

Insights about prostate cancer resistance could lead to treatment strategies

Metastatic breast cancer patients report high level of financial impact

Study focused on improving radiation treatment for cancers in pet dogs

Susan G. Komen awards UNC Lineberger $1.1M for breast cancer research

UNC researchers awarded emerging challenges grants

Yuma News Now: NIH-funded study uncovers range of molecular alterations in head and neck cancers, new potential drug targets

Yuma News Now: Mayo Clinic-led study validates tool for patient reporting of side effects in cancer clinical trials

Yahoo! News: Women beware! 7 or more alcoholic drinks a week ups risk of cancer

Yahoo! News: This woman’s skin cancer selfie may have helped save lives